Drugmakers Fined Record £260M For Overcharging NHS
Britain's competition watchdog said Thursday it has fined a group of pharmaceutical companies including U.K. giant Accord a total of £260 million ($360 million) for overcharging the National Health Service for...To view the full article, register now.
Already a subscriber? Click here to view full article